Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
R03AC14
|
| gptkbp:CASNumber |
gptkb:60644-46-8
|
| gptkbp:drugClass |
beta-2 adrenergic agonist
|
| gptkbp:hasMolecularFormula |
C12H18Cl2N2O
|
| https://www.w3.org/2000/01/rdf-schema#label |
60644-46-8
|
| gptkbp:legalStatus |
banned in sports
|
| gptkbp:meltingPoint |
174-175°C
|
| gptkbp:molecularWeight |
277.19 g/mol
|
| gptkbp:name |
gptkb:Clenbuterol
|
| gptkbp:regulates |
gptkb:World_Anti-Doping_Agency
|
| gptkbp:routeOfAdministration |
oral
inhalation |
| gptkbp:sideEffect |
headache
nervousness tachycardia muscle tremor |
| gptkbp:synonym |
Clenbuterol hydrochloride
Spiropent |
| gptkbp:usedFor |
treatment of asthma
bronchodilator |
| gptkbp:bfsParent |
gptkb:relaxin
|
| gptkbp:bfsLayer |
6
|